Hodgkin Lymphoma News and Research

RSS

NCCN expands agreement to improve cancer care in Vietnam

The National Comprehensive Cancer Network (NCCN) today announced the signing of a new agreement with the Viet Nam National Cancer Hospital (K Hospital) and The Vietnam Cancer Association (VCA), expanding a longstanding collaboration to improve cancer care through the adaptation and use of evidence-based clinical practice guidelines.

5 Nov 2026

OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of four newly available IVDR-certified CytoCell® fluorescence in situ hybridization (FISH) probes as part of its ongoing commitment to transition the CytoCell FISH portfolio from CE marking under the IVD Directive (IVDD) to the IVD Regulation (IVDR) ahead of the Class C deadline of 31 December 2028.

3 Nov 2026

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

Results from a phase I clinical trial led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers.

13 Oct 2026

NCCN introduces first-ever evidence-based guidelines for pediatric bone sarcoma

Today, the National Comprehensive Cancer Network (NCCN) published the first-ever edition of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Bone Sarcoma.

1 Oct 2026

Newly-discovered protein acts as off switch for human immune cells

Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.

3 Aug 2026

Midpregnancy herbicide exposure linked to increased preterm birth risk

Exposure to a widely used herbicide during the middle months of pregnancy may increase the chance of giving birth too early, before 37 weeks, a new study shows.

31 Jul 2026

Midpregnancy herbicide exposure linked to increased risk of preterm birth

Exposure to a widely used herbicide during the middle months of pregnancy may increase the chance of giving birth too early, before 37 weeks, a new study shows.

22 Jul 2026

AACR report highlights unequal burden of cancer in the United States

The American Association for Cancer Research (AACR) today released its Cancer Disparities Progress Report 2026, a comprehensive analysis of the unequal burden of cancer in the United States.

24 Jun 2026

Higher BMI raises risk for 19 cancers as global review expands the obesity-cancer link

A major systematic review and meta-analysis links higher BMI to increased risk of 19 cancer types, including leukemia, non-Hodgkin lymphoma, bladder cancer, and glioma, which were not previously recognized in major consensus reports. The study also reveals regional and sex-based variation in cancer risk, with genetic evidence generally supporting many observational links while highlighting the need for more diverse global cohorts.

17 Jun 2026

Study reframes Hodgkin lymphoma as a cancer of failed cell development

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis."

24 Apr 2026

Young cancer survivors face double the risk of later cancers

Survivors of cancer in their teen and young adult years are at double the risk of most types of later cancers, according to research from Alberta published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251381.

13 Apr 2026

Precision medicine tools offer hope for patients with rare blood cancers

Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers that arise in immune cells called B cells—yet the same is not true for patients with more rare lymphoma types that originate in immune cells called T cells.

9 Apr 2026

Pirtobrutinib shows superior outcomes compared to common first-line combination treatment for CLL/SLL

In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when compared with bendamustine plus rituximab (BR) in patients with previously untreated chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

10 Dec 2025

Lymphocyte levels help predict outcomes after CAR T-cell therapy in non-Hodgkin lymphoma

Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to research from physicians at Fox Chase Cancer Center and Temple Health.

8 Dec 2025

Evidence grows for pirtobrutinib as a safer and effective alternative for CLL and SLL

Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms of overall response rate in the first head-to-head comparison with ibrutinib, a covalent BTK inhibitor.

7 Dec 2025

New trial shows major survival gains with epcoritamab added to standard R2 therapy

In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab in addition to the standard second-line regimen versus the standard regimen alone.

7 Dec 2025

Hodgkin Lymphoma News and Research

NCCN expands agreement to improve cancer care in Vietnam

OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

NCCN introduces first-ever evidence-based guidelines for pediatric bone sarcoma

Newly-discovered protein acts as off switch for human immune cells

Midpregnancy herbicide exposure linked to increased preterm birth risk

Midpregnancy herbicide exposure linked to increased risk of preterm birth

AACR report highlights unequal burden of cancer in the United States

Higher BMI raises risk for 19 cancers as global review expands the obesity-cancer link

Study reframes Hodgkin lymphoma as a cancer of failed cell development

Young cancer survivors face double the risk of later cancers

Precision medicine tools offer hope for patients with rare blood cancers

Pirtobrutinib shows superior outcomes compared to common first-line combination treatment for CLL/SLL

Lymphocyte levels help predict outcomes after CAR T-cell therapy in non-Hodgkin lymphoma

Evidence grows for pirtobrutinib as a safer and effective alternative for CLL and SLL

New trial shows major survival gains with epcoritamab added to standard R2 therapy

New consortium aims to fast-track breakthroughs against follicular lymphoma

Novel model expands fertility options for cancer patients

Common chemical tetrachloroethylene may be harmful to the liver

Rare case of pancreatic Hodgkin lymphoma is often misdiagnosed as pancreatic adenocarcinoma

Everything you should know about lymphoma eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News